JPRN-UMIN000024227
Completed
未知
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infection - Daclatasvir and Asunaprevir therapy for hemodialyzed ptatients
others0 sites130 target enrollmentSeptember 29, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hemodialyzed patients with genotype 1 chronic hepatitis C infection
- Sponsor
- others
- Enrollment
- 130
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1patients with heart failure 2patients with decompensated cirrhosis 3patients with allergic to NS5A inhibitor or HCV PI inhibitor 4 patients with HCC or other malignant disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with chronic hepatitis Chemodialyzed patients with chronic hepatitis CJPRN-UMIN000016355Hokkaido University Hospital100
Completed
Not Applicable
Efficacy and safety of daclatasvir and asunaprevir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000016181shonan kamakura general hospital30
Completed
Not Applicable
Efficacy and safety of daclatasvir and asunaprevir in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000015247Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology350
Unknown
Phase 4
Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis CHepatitis C, ChronicNCT02639585Pusan National University Hospital32
Completed
Phase 3
A Phase 3 Study with Asunaprevir and Daclatasvir (DUAL) for Null or Partial Responders to Peginterferon Alfa and Ribavirin (P/R), Intolerant or Ineligible to P/R Subjects and Treatment-Naive Subjects with Chronic Hepatitis C Genotype 1b Infection.;+ Pharmacogenetics Blood Sample Amendment Number 01 - Site Specific (version 1.0, dated 13-Mar-12)Hepatitis CChronic Hepatitis C infection or Chronic HCV10047438NL-OMON37621Bristol-Myers Squibb18